Trials / Completed
CompletedNCT02222883
Prevalence of BRCA in Patients With Ovarian Cancer
Prevalence of BRCA in Patients With Primary or Platinum Sensitive Recurrent Ovarian Cancer.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 530 (actual)
- Sponsor
- AGO Research GmbH · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this prospective registration and translational research study is to evaluate the praevalence of BRCA regarding germline and somatic mutations.
Detailed description
Explorative analysis will be performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Testing of BRCA status regarding germline and somatic mutation |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2014-08-21
- Last updated
- 2021-06-16
Locations
20 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02222883. Inclusion in this directory is not an endorsement.